La Jolla Pharmaceutical Company (LJPC) Social Stream



La Jolla Pharmaceutical Company (LJPC): $6.22

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add LJPC to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#14 of 398

in industry

LA JOLLA PHARMACEUTICAL CO (LJPC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LJPC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-05-16 1 $4 $4 $4 $6.17 -35.17%
2022-07-13 1 $6.23 $6.23 $6.23 $6.17 0.97%

Price Target Last Issued July 13, 2022

The Trend in the Analyst Price Target


LJPC's average price target has moved down $5.71 over the prior 17 months.

Over the past 46 weeks, LJPC's average upside potential has been 5.66%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-28 2 4.50 4.50 4.50 4.37 2.97%
2021-09-18 2 4.50 4.50 4.50 4.02 11.94%
2022-03-14 1 4.00 4.00 4.00 3.93 1.78%
2022-05-16 1 4.00 4.00 4.00 4.16 -3.85%
2022-07-13 1 6.23 6.23 6.23 6.17 0.97%

LJPC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


Over the past 26 months, LJPC's average broker recommendation rating worsened by 1.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LJPC as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, LA JOLLA PHARMACEUTICAL CO's number of analysts covering the stock is greater than practically none of them.
  • LJPC has a lower variance in analysts' estimates than nearly 100% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LA JOLLA PHARMACEUTICAL CO's upside potential (average analyst target price relative to current price) is higher than 6.62% of them.
  • LJPC has a greater average analyst price target than 13.9% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LA JOLLA PHARMACEUTICAL CO are LIFE, LCTX, and JSPR.

Is LJPC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!